ArticleClinical ophthalmology (Auckland, N.Z.)2026
Comparative Study of Outflow Facility and Intraocular Pressure in Kahook Dual Blade and iStent Inject - A Consecutive Case Series.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the effects of Kahook Dual Blade (KDB) ab-interno trabeculectomy and iStent inject on tonographic outflow facility in glaucoma subjects. Design: Comparative non-randomised observational study. Participants: Adult pseudophakic patients with open angle glaucoma or ocular hypertension with sub-optimal intraocular pressure (IOP) control despite maximum tolerated medical treatment. Methods: All patients underwent washout of all glaucoma medications before measurement of tonographic outflow facility (TOF) and IOP. Washout TOF and IOP were repeated 3 months after the surgery with either KDB or iStent inject. Main Outcome Measures: Tonographic outflow facility, intraocular pressure, complication rates and number of glaucoma medications. Results: A total of 40 patients participated in the study, 20 eyes of 20 patients were included in each group. 20 untreated eyes acted as control eyes. All patients in the iStent group underwent drop washout. Six patients in the KDB group were unable to safely undergo washout. At the 3-months post-operative visit, the mean post washout IOP was reduced by 20% (25.0±7.1 mmHg at baseline vs 19.6±3.5 mmHg at 3 months, p=0.02) whilst TOF was doubled (0.050±0.01 µL/min/mmHg at baseline vs 0.098±0.06-µL/min/mmHg at 3 months, p=0.04) from baseline in the KDB group. The iStent group showed a nonsignificant increase in mean TOF from 0.110±0.08 µL/min/mmHg at baseline to 0.145±0.09 µL/min/mmHg at 3 months (p= 0.18) and a nonsignificant decrease in median IOP 21mmHg vs 18.7mmHg (p = 1.0), Control eyes showed no significant change in the mean IOP (20.8±5.5 mmHg at baseline vs 20.5±6.1 mmHg at 3 months, p = 0.86) and TOF (baseline 0.120±0.08-µL/min/mmHg vs 3 months 0.124±0.08 -µL/min/ mmHg, p = 0.88). Conclusion: We demonstrated that there is a statistically significant reduction in IOP and doubling of TOF following KDB. However, patients did not show significant changes in IOP or outflow facility after standalone iStent inject implantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.